DIO Corporation (KOSDAQ:039840)
South Korea · Delayed Price · Currency is KRW 9,680.00
-310.00 (-3.10%)
Sep 22, 2026, 3:30 PM KST
DIO Corporation Market Cap
DIO Corporation has a market cap or net worth of 123.97 billion as of September 21, 2026. Its market cap has decreased by -48.74% in one year.
Market Cap
123.97B
Enterprise Value
161.43B
Revenue
174.45B
Ranking
n/a
PE Ratio
6.33
Stock Price
9,680.00
ChartMarket Cap Chart
Since March 1, 2001, DIO Corporation's market cap has increased from 25.42B to 123.97B, an increase of 387.64%. That is a compound annual growth rate of 6.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 123.97B | -45.18% |
| Dec 30, 2025 | 226.14B | 1.27% |
| Dec 30, 2024 | 223.31B | -31.36% |
| Dec 28, 2023 | 325.35B | 11.83% |
| Dec 29, 2022 | 290.93B | -47.39% |
| Dec 30, 2021 | 553.05B | 17.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.83T |
| Celltrion | 40.98T |
| ALTEOGEN | 17.65T |
| Samsung Epis Holdings | 8.12T |
| Shinhung | 133.59B |
| Genexine | 131.89B |
| Macrogen | 130.10B |
| Kyongbo Pharmaceutical | 129.34B |